This ClinicalTrials.gov entry describes a phase 2 interventional study evaluating Project ECHO telementoring to enhance palliative care for patients with advanced cancer and their caregivers in underserved regions across Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia. The study aims to assess experiences and satisfaction with care, with the overarching goal of strengthening healthcare workforce capacity and expanding access to specialty palliative care in rural and underserved settings. Project ECHO is presented as a medical education and care-management model intended to empower local clinicians to deliver higher-quality palliative care to more patients in their communities. The trial focuses on patients with advanced malignant solid tumors or hematopoietic/lymphoid neoplasms and their caregivers, evaluating perceived quality and satisfaction as outcomes to inform potential improvements in care delivery and workforce training. Key design details include an estimated enrollment of 312 participants, a primary purpose of supportive care, and recruitment ongoing with an estimated completion date in December 2026. The available information does not specify the exact measurement tools, primary endpoints, or comparative control conditions, indicating some uncertainty regarding methodology.
Official title: ECHO Telementoring to Improve Quality Palliative Care in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
Summary: This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live. Understanding the experiences and satisfaction of patients and caregivers may help improve healthcare workforce capacity and increase access to specialty care for the world's rural and underserved populations.
Conditions: Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm
Study type: INTERVENTIONAL
Primary purpose: SUPPORTIVE CARE
Phases: PHASE2
Enrollment: 312 (ESTIMATED)
Status: RECRUITING
Completion: 2026-12-31 (ESTIMATED)